Trial of Forodesine in Patients With Relapsed B-cell Chronic Lymphocytic Leukemia
Phase 1
Terminated
- Conditions
- First Posted Date
- 2008-03-28
- Last Posted Date
- 2010-03-31
- Lead Sponsor
- Mundipharma Research Limited
- Target Recruit Count
- 1
- Registration Number
- NCT00646165
- Locations
- 🇪🇸
H. Clinic I Provincial, Barcelona, Spain
A Study to Assess the Safety and Tolerability of Oxycodone Hydrochloride 50mg/mL Administered as an Infusion
Phase 3
Terminated
- Conditions
- First Posted Date
- 2008-02-29
- Last Posted Date
- 2018-10-24
- Lead Sponsor
- Mundipharma Research Limited
- Target Recruit Count
- 33
- Registration Number
- NCT00626600
- Locations
- 🇬🇧
Royal Marsden Hospital, London, United Kingdom
An Open, Randomised, Parallel Group Multicentre Study to Compare the Efficacy and Safety of Flutiform® pMDI vs Fluticasone pMDI Plus Formoterol DPI in Adolescent and Adult Subjects With Mild to Moderate-severe Persistent, Reversible Asthma
- First Posted Date
- 2007-11-26
- Last Posted Date
- 2018-10-24
- Lead Sponsor
- Mundipharma Research Limited
- Target Recruit Count
- 227
- Registration Number
- NCT00563056
- Locations
- 🇳🇱
Research site, Nieuwegein, Netherlands
🇬🇧Research Site, Chesterfield, United Kingdom
Study of FLUTIFORM® VS Seretide® in Paediatric Subjects With Asthma
Phase 3
Completed
- Conditions
- First Posted Date
- 2007-05-21
- Last Posted Date
- 2018-10-24
- Lead Sponsor
- Mundipharma Research Limited
- Target Recruit Count
- 211
- Registration Number
- NCT00475813
Efficacy and Safety of Flutiform® pMDI in Adult Patients With Mild to Moderate-severe Reversible Asthma
Phase 3
Completed
- Conditions
- First Posted Date
- 2007-05-21
- Last Posted Date
- 2018-10-24
- Lead Sponsor
- Mundipharma Research Limited
- Target Recruit Count
- 228
- Registration Number
- NCT00476073
- Locations
- 🇬🇧
Dr Blagden, Chesterfield, United Kingdom
© Copyright 2024. All Rights Reserved by MedPath